Holen Sie sich die Stockscreener-App
0.5783
3.29%
-0.0197
Handel nachbörslich:
.58
0.0017
+0.29%
Schlusskurs vom Vortag:
$0.598
Offen:
$0.6046
24-Stunden-Volumen:
4.34M
Relative Volume:
0.84
Marktkapitalisierung:
$174.48M
Einnahmen:
$52.29M
Nettoeinkommen (Verlust:
$-134.84M
KGV:
-0.7711
EPS:
-0.75
Netto-Cashflow:
$-117.11M
1W Leistung:
-8.08%
1M Leistung:
-15.32%
6M Leistung:
-20.60%
1J Leistung:
-69.24%
1-Tages-Spanne:
$0.5675
$0.6055
1-Wochen-Bereich:
$0.562
$0.6283
52-Wochen-Spanne:
$0.4111
$3.179
Sangamo Therapeutics Inc Stock (SGMO) Company Profile
Firmenname
Sangamo Therapeutics Inc
Sektor
Branche
Telefon
(510) 970-6000
Adresse
501 CANAL BLVD., RICHMOND, CA
Vergleichen Sie SGMO mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
SGMO
Sangamo Therapeutics Inc
|
0.5783 | 180.42M | 52.29M | -134.84M | -117.11M | -0.75 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.00 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
642.25 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
434.07 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
826.28 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
186.23 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
Sangamo Therapeutics Inc Stock (SGMO) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-12-13 | Hochstufung | Truist | Hold → Buy |
| 2024-12-10 | Bestätigt | H.C. Wainwright | Buy |
| 2023-11-03 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform |
| 2023-04-28 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2023-02-27 | Hochstufung | Wedbush | Neutral → Outperform |
| 2023-01-06 | Herabstufung | BofA Securities | Buy → Neutral |
| 2022-06-13 | Fortgesetzt | Wedbush | Neutral |
| 2021-05-04 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2021-01-07 | Fortgesetzt | Guggenheim | Neutral |
| 2021-01-06 | Eingeleitet | Stifel | Hold |
| 2020-12-16 | Fortgesetzt | H.C. Wainwright | Buy |
| 2020-09-08 | Eingeleitet | BofA Securities | Buy |
| 2020-07-07 | Eingeleitet | SunTrust | Buy |
| 2019-08-26 | Eingeleitet | H.C. Wainwright | Buy |
| 2018-11-14 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2018-11-09 | Herabstufung | Guggenheim | Buy → Neutral |
| 2018-10-10 | Eingeleitet | Guggenheim | Buy |
| 2018-06-20 | Eingeleitet | BofA/Merrill | Buy |
| 2017-11-15 | Hochstufung | Piper Jaffray | Neutral → Overweight |
| 2017-06-22 | Fortgesetzt | Jefferies | Buy |
| 2016-11-01 | Herabstufung | Wedbush | Outperform → Neutral |
| 2016-10-19 | Herabstufung | Piper Jaffray | Overweight → Neutral |
| 2015-12-04 | Eingeleitet | Wells Fargo | Outperform |
| 2015-10-23 | Fortgesetzt | Jefferies | Buy |
| 2013-05-03 | Eingeleitet | BioLogic Equity Research | Sell |
| 2011-02-23 | Bestätigt | JMP Securities | Mkt Outperform |
| 2010-07-29 | Bestätigt | Wedbush | Outperform |
| 2009-10-19 | Eingeleitet | Brean Murray | Sell |
| 2009-10-07 | Bestätigt | Leerink Swann | Outperform |
| 2009-08-25 | Bestätigt | JMP Securities | Mkt Outperform |
Alle ansehen
Sangamo Therapeutics Inc Aktie (SGMO) Neueste Nachrichten
What analysts say about Sangamo Therapeutics Inc GBY stockMarket Entry Points & Free Extraordinary Earning Power - earlytimes.in
How buybacks impact Sangamo Therapeutics Inc. stock valuePortfolio Performance Summary & AI Forecasted Entry/Exit Points - newser.com
Sangamo Therapeutics Announces Third Quarter 2025 Earnings Call - Zenopa
Will Sangamo Therapeutics Inc. stock outperform Nasdaq indexWeekly Trend Recap & Free Weekly Watchlist of Top Performers - newser.com
Is Sangamo Therapeutics Inc. stock in correction or buying zoneJuly 2025 Short Interest & AI Enhanced Execution Alerts - newser.com
Is Sangamo Therapeutics Inc. stock a safe haven asset2025 Earnings Surprises & Entry Point Strategy Guides - newser.com
Tick level data insight on Sangamo Therapeutics Inc. volatility2025 Major Catalysts & Fast Gain Stock Tips - newser.com
How Sangamo Therapeutics Inc. stock reacts to bond yieldsEarnings Risk Report & Risk Managed Investment Entry Signals - newser.com
Real time pattern detection on Sangamo Therapeutics Inc. stock2025 Winners & Losers & Growth Focused Stock Pick Reports - newser.com
Using AI based signals to follow Sangamo Therapeutics Inc.Weekly Stock Recap & Consistent Growth Equity Picks - newser.com
What analyst consensus says on Sangamo Therapeutics Inc. stock2025 Pullback Review & Verified Momentum Watchlists - newser.com
Detecting price anomalies in Sangamo Therapeutics Inc. with AIJuly 2025 Decliners & Free Daily Entry Point Trade Alerts - newser.com
What machine learning models say about Sangamo Therapeutics Inc.Profit Target & AI Based Trade Execution Alerts - newser.com
Sangamo Therapeutics Inc. stock chart pattern explainedMarket Activity Summary & Daily Entry Point Trade Alerts - newser.com
How Sangamo Therapeutics Inc. (GBY) stock reacts to monetary easingJuly 2025 Outlook & Stepwise Entry/Exit Trade Alerts - newser.com
How hedge fund analytics apply to Sangamo Therapeutics Inc. stock2025 Earnings Surprises & Stepwise Trade Signal Guides - newser.com
Why retail investors favor Sangamo Therapeutics Inc. stockJuly 2025 Chart Watch & Reliable Momentum Entry Alerts - newser.com
What analysts say about Sangamo Therapeutics Inc stockEarnings Per Share Trends & Big Returns, Small Investment – Learn How - earlytimes.in
Sangamo Therapeutics (NASDAQ: SGMO) to host earnings call Nov. 6 at 8:30 a.m. ET - Stock Titan
We're Hopeful That Sangamo Therapeutics (NASDAQ:SGMO) Will Use Its Cash Wisely - Yahoo Finance
Published on: 2025-10-29 21:25:18 - newser.com
Sangamo Biosciences Granted Nasdaq Compliance Extension - TipRanks
Finanzdaten der Sangamo Therapeutics Inc-Aktie (SGMO)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.64%
0.35%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):